Seemant Chaturvedi/ University of Maryland School of Medicine
Aug 6, 2025, 06:37
Seemant Chaturvedi: Could Tirofiban Improve Outcomes in Acute Ischemic Stroke?
NEJM Journal Watch has shared a post on X:
“Tirofiban as Thrombolysis Adjunct for Patients with Acute Ischemic Stroke
Patients might have benefited from tirofiban, although these findings require confirmation before clinicians change their practice.”
Read the full review article here.
Article: Tirofiban as Thrombolysis Adjunct for Patients with Acute Ischemic Stroke
Author: Seemant Chaturvedi, MD, reviewing Tao C et al. N Engl J Med 2025 Jul 3
Stay updated with latest scientific advancements on stroke with Hemostasis Today.
-
Jan 8, 2026, 05:51Dominika Jędrzejewska Akbaş Links Sleep Deprivation, Obesity, and Stroke
-
Jan 8, 2026, 05:42Rob Maloney: A Bruise that Did Not Go Away…
-
Jan 8, 2026, 05:33Matías J Alet on Treating Early Neurological Deterioration in Lacunar Stroke
-
Jan 8, 2026, 05:11Thomas Meinel Shares The English Stroke Guidelines 2026
-
Jan 8, 2026, 05:03Hilla Ben-Pazi: We Were Pleased to Receive a Grant from the Israeli Ministry of Economy
-
Jan 8, 2026, 04:24Nikhil Agrawal Breaks Down Perioperative Anticoagulation
-
Jan 8, 2026, 03:58Louise St Germain Bannon Appointed Interim Executive Director of ISTH
-
Jan 8, 2026, 03:47Wolfgang Miesbach on Fernando Corrales-Medina’s Team’s Latest Cross-Sectional Study on Haemophilia
-
Jan 8, 2026, 03:28Rick Matthews: Powerful Perspective from Erin and the NBCA Team